mAbxience Revenue and Competitors
Estimated Revenue & Valuation
- mAbxience's estimated annual revenue is currently $169.3M per year.
- mAbxience's estimated revenue per employee is $155,000
Employee Data
- mAbxience has 1092 Employees.
- mAbxience grew their employee count by 9% last year.
mAbxience's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Analytical development | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | Head Regulatory Operations | Reveal Email/Phone |
5 | Controller technician | Reveal Email/Phone |
6 | Associate Director Regulatory Affairs CMC | Reveal Email/Phone |
7 | Director médico | Reveal Email/Phone |
8 | Chief Science Officer | Reveal Email/Phone |
9 | Garantía de Calidad y Director Técnico en mAbxience Planta Garín | Reveal Email/Phone |
10 | Director | Reveal Email/Phone |
mAbxience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10.4M | 67 | -26% | N/A | N/A |
#2 | $42.9M | 277 | 2% | N/A | N/A |
#3 | $53.3M | 344 | 11% | N/A | N/A |
#4 | $169.3M | 1092 | 9% | N/A | N/A |
#5 | $13.6M | 88 | 5% | N/A | N/A |
#6 | $25.9M | 167 | 43% | N/A | N/A |
#7 | $26.5M | 171 | 8% | N/A | N/A |
#8 | $8.8M | 57 | -5% | N/A | N/A |
#9 | $11.8M | 76 | 4% | N/A | N/A |
#10 | N/A | 60 | 20% | N/A | N/A |
What Is mAbxience?
mAbxience is a high growth international biotechnology company specialized in the research, development, manufacture and global commercialization of biopharmaceutical products to treat and prevent diseases across different therapeutic areas.
keywords:N/AN/A
Total Funding
1092
Number of Employees
$169.3M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 1117 | 19% | N/A |
#2 | N/A | 1131 | 8% | N/A |
#3 | $233M | 1148 | 8% | N/A |
#4 | $239.3M | 1179 | 5% | N/A |
#5 | $252.7M | 1257 | 11% | N/A |